![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Immunological assessment of HBeAg-negative Chronic
Hepatitis B patient responses following anti-PD-1 treatment
|
|
|
Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
Daniel Verdon1, Anna E. Brooks1, 4, Anuj Gaggar2, Jacky Woo2, Mani Subramanian2, Christian Schwabe3, Edward J. Gane3, Rod Dunbar1, 4
1University of Auckland, Auckland, New Zealand, 2Gilead Sciences, Foster City, CA, United States,
3Auckland Clinical Studies, Auckland, New Zealand, 4Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand
![1110171](../images/111017/111017-9/1110171.gif)
![1110173](../images/111017/111017-9/1110173.gif)
![1110174](../images/111017/111017-9/1110174.gif)
![1110175](../images/111017/111017-9/1110175.gif)
![1110176](../images/111017/111017-9/1110176.gif)
![1110177](../images/111017/111017-9/1110177.gif)
![1110178](../images/111017/111017-9/1110178.gif)
![1110179](../images/111017/111017-9/1110179.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|